BRIDGEWATER, N.J., Feb. 26 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) approved Apidra(R) SoloSTAR(R ...

The FDA has approved Apidra SoloSTAR (insulin glulisine[rDNA origin] injection, from sanofi-aventis), a prefilled disposable pencontaining Apidra. Apidra SoloSTAR makes administration of insulin ...

PARIS, February 14 Sanofi-aventis announcedtoday that the Chicago Athenaeum Museum of Architecture and Design hasawarded a 2007 GOOD DESIGN(TM) Award for the new SoloSTAR(R) disposableinsulin ...

Sanofi-aventis has won FDA approval for Apidra SoloSTAR, a prefilled disposable pen, for children with type 1 diabetes and adults with type 1 or 2 diabetes. Apidra, which has been on the market in the ...

Sanofi announced today, at the 71st Scientific American Diabetes Association Sessions 2011, the results of three studies showing that people with diabetes using Sanofi insulins Lantus(R) and/or Apidra ...

PARIS, Feb 26 (Reuters) - Sanofi-Aventis has won U.S. approval to market its Apidra Solostar injection pen which contains insulin to treat diabetes, the world's third-biggest drugmaker said on ...

European Commission approves Apidra for diabetes Apidra has a rapid onset and short duration of action which allows covering the postprandial hyperglycaemic peaks. It should normally be used in ...

The letter also says Sanofi expects to return to normal supply levels by the first quarter of next year. In the meantime, the company recommends that doctors consider switching patients to Apidra ...

Apidra SoloSTAR (insulin glulisine [rDNA origin] injection, from sanofi-aventis), a prefilled disposable pen containing Apidra, is now available. Apidra SoloSTAR makes administration of insulin more ...

March 3, 2009 — On February 26, sanofi-aventis announced that a prefilled disposable pen containing insulin glulisine (Apidra SoloSTAR) was approved by the US Food and Drug Administration (FDA). This ...